dekafin-1

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedekafin-1
Drug Alias NameFGFR agonist (Enkam)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnkam Pharmaceuticals A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnkam Pharmaceuticals A/S
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A